Cut-and-paste DNA editing. FDA-approved. Nobel Prize. We're rewriting life.
CRISPR gene editing gives humanity the ability to cut-and-paste DNA like editing a text file, a feat recognized with the 2020 Nobel Prize for Jennifer Doudna and Emmanuelle Charpentier. In 2023, the FDA approved Casgevy, the first CRISPR-based therapy, to cure sickle cell disease, marking a 100% correction rate in clinical trials for transfusion-dependent patients. This technology, adapted from a bacterial immune system, is 10 times more precise than earlier gene-editing methods like ZFNs, outperforming #2's particle collisions in tangible medical impact. The ethical implications are staggering; the medical potential is unlimited. We are literally rewriting the source code of life.
Comments on "CRISPR Gene Editing"
Create a free account or sign in to join the discussion.
Sign in to join the conversation